Table 2.
Number of respondents who believe that the indicated TBD occurs in the area where they live (2009).
| Geographic region | LD n (% within region) |
RMSF n (% within region) |
None or “Have not heard of any of these TBDs”a n (% within region) |
|---|---|---|---|
| Overall | 2943 (63.7) | 959 (20.2) | 1559 (31.6) |
| New England | 170 (86.1) | 18 (11.5) | 30 (13.9) |
| Mid-Atlantic | 502 (78.7) | 64 (7.6) | 146 (20.8) |
| East North Central | 552 (68.6) | 89 (10.9) | 234 (28.6) |
| West North Central | 242 (77.9) | 82 (20.6) | 70 (19.3) |
| South Atlantic | 597 (66.2) | 265 (28.3) | 289 (28.8) |
| East South Central | 206 (63.6) | 122 (38.3) | 109 (30.2) |
| West South Central | 242 (49.4) | 110 (25.8) | 236 (45.4) |
| Mountain | 157 (51.1) | 148 (48.1) | 116 (30.3) |
| Pacific | 275 (38.9) | 61 (9.5) | 329 (55.1) |
a
The TBDs listed in this survey question were Lyme disease, RMSF, anaplasmosis, babesiosis, ehrlichiosis, STARI, tick-borne relapsing fever, and tularemia (Table 1).